Dr Reddy’s Labs launches osteoporosis drug in the US

2016-11-11T15:10:29+00:00 On

Dr Reddy’s Laboratories Ltd said it launched raloxifene hydrochloride tablets –used to treat osteoporosis — in the US market. Raloxifene hydrochloride tablets are a therapeutic equivalent generic version of Evista (raloxifene hydrochloride) tablets. A generic drug is a pharmaceutical drug that is equivalent…

Mylan and Biocon submits breast cancer drug application to USFDA

Mylan and Biocon submits breast cancer drug application to USFDA

2016-11-09T11:23:34+00:00 On

Mylan N.V. and Biocon Ltd. said they submitted Mylan’s biologics license application for a proposed biosimilar Trastuzumab, to the U.S. Food and Drug Administration. Biosimilar trastuzumab is a proposed biosimilar to branded Trastuzumab, which is indicated to treat certain HER2-positive breast and…

Aarti Industries to return Rs 96 cr to shareholders via buyback

Aarti Industries to return Rs 96 cr to shareholders via buyback

2016-10-18T14:52:05+00:00 On

Speciality Chemicals company Aarti Industries Ltd said it will buy back12 lakh equity shares at Rs 800 each, aggregating to Rs 96 cr. The company´s Board of Directors approved the equity shares — representing up to 1.44% of the company’s base. “The public…

Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets

Marksans Pharma gets USFDA approval for synthetic Vitamin D tablets

2016-10-18T12:24:26+00:00 On

Marksans Pharma Ltd said the United States Food & Drug Administration has given its approval for its paricalcitol capsules — a synthetic equivalent of Vitamin D. Vitamin D is important for the absorption of Calcium from the stomach and for the functioning…

Fortis Healthcare to take loan of Rs 77.6 cr from Singapore bank

2016-10-07T16:08:17+00:00 On

Fortis Healthcare said it´s Mauritius subsidiary Fortis Healthcare international Ltd, has will take a loan of SGD 165 mln (Rs 77.6 crore) from Singapore-based Consortium of Bankers. “Fortis Healthcare Ltd has being holding the company, is giving guarantee on behalf of FHIL…

Cadila to launch immunosuppressant drug in India

Cadila to launch immunosuppressant drug in India

2016-10-06T12:49:37+00:00 On

Cadila Healthcare, a Ahmedabad headquartered pharmaceutical company owned by Zydus Group, said it has partnered with Switzerland-based global biopharmaceutical company Neovii to launch an drug to reduce the strength of the body’s immune system in India. The drug named Grafalon is extensively…

Almebic Pharmaceuticals receives inspection report from USFDA

Almebic Pharmaceuticals receives inspection report from USFDA

2016-10-05T11:56:08+00:00 On

Alembic Pharmaceuticals Ltd., said it received an Establishment Inspection Report from the United States Food and Drug Administration for the inspection carried out at their formulation facility at Panelav, Gujarat. The FDA has the authority to inspect any establishment in which food…

Shilpa Medicare receives USFDA approval for generic bone marrow drug

Shilpa Medicare receives USFDA approval for generic bone marrow drug

2016-10-04T11:49:12+00:00 On

Shilpa Medicare Ltd said it received an approval from the United states Food & Drug Administration for Azacitidine injection. Azacitidine is used to treat myelodysplastic syndrome – a group of conditions in which the bone marrow produces blood cells that are misshapen…

FDA observations ‘primarily procedural’ –

FDA observations ‘primarily procedural’ –

2016-09-30T13:27:03+00:00 On

USFDA issued four observations about Cipla’s manufacturing facilities in Goa after conducting an audit, the company said. Cipla has three facilities in Goa. “The observations were primarily procedural in nature and the company has already responded to these observations,” said the pharma company. Further…

Lupin receives FDA approval for generic Namenda XR dementia capsules

Lupin receives FDA approval for generic Namenda XR dementia capsules

2016-09-29T15:24:46+00:00 On

Pharma Major Lupin Ltd said it received final approval from United States Food and Drug Administration for selling Memantine Hydrochloride extended-release capsules, a generic version of Allergan’s Namenda XR capsules. Namenda XR extended-release capsules are approved by the USFDA for the treatment…

Suven Life Sciences gets two product patents in India and Japan

Suven Life Sciences gets two product patents in India and Japan

2016-09-26T13:07:12+00:00 On

Drug manufacturer Suven Life Sciences Ltd said it got two product patents in India and Japan for to a new compound for the treatment of disorders associated with Neurodegenerative diseases. The patents are valid through 2026-2032. The granted claims include a class of…

Marksans Pharma gets USFDA approval for sale of anti-allergy drug

Marksans Pharma gets USFDA approval for sale of anti-allergy drug

2016-09-26T11:22:05+00:00 On

Marksans Pharma Limited, an Indian pharmaceutical company, said it has received approval from the USFDA for the sale sale of its Loratadine Liquid Filled Capsules 10 mg in the US market. Loratadine is an antihistamine that reduces the effects of natural chemical…

Lincoln Pharma develops oral spray version of Ondansetron anti-nausea drug

Lincoln Pharma develops oral spray version of Ondansetron anti-nausea drug

2016-09-22T14:22:20+00:00 On

Lincoln Pharmaceuticals Ltd said it developed and launched an oral spray version of Ondansetron anti-nausea drug. Ondansetron is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy), radiation therapy and also in the prevention and treatment for nausea and…

Aurobindo Pharma to launch HIV drug in Africa this year, gets tentative FDA nod

Aurobindo Pharma to launch HIV drug in Africa this year, gets tentative FDA nod

2016-09-22T13:21:10+00:00 On

Aurobindo Pharma Limited, a pharmaceutical manufacturing company based in Hyderabad, said it received a tentative approval for HIV drug Dolutegravir from US Food & Drug Administration. It is the first FDA approval of a generic version of Dolutegravir. Through a tie up…

NBCC gets Rs 440 crore ESIC contract to build hospitals

NBCC gets Rs 440 crore ESIC contract to build hospitals

2016-09-20T18:10:09+00:00 On

NBCC (India) Ltd, said it got a contract worth Rs 440 crore for the construction of hospitals in Haridwar, Dehradun and Indore from Employee’s State Insurance Corporation, Ministry of Labour & Employment. As per the contract, the NBCC should build 100 bedded…

Worried about your diet? Try CSE’s new online interactive tool

Worried about your diet? Try CSE’s new online interactive tool

2016-09-20T14:58:27+00:00 On

Centre for Science and Environment (CSE) has launched an online interactive tool to help people know about their food and dietary habits. “What we eat affects our health. But most of us do not know what we eat and how it affects our…

Sharon Bio Medicines receives FDA approval for Tajola API plant

Sharon Bio Medicines receives FDA approval for Tajola API plant

2016-09-20T13:29:54+00:00 On

Indian Pharmaceutical company Sharon bio medicine Ltd said it received the Establishment Inspection Report (EIR) from United States Food and Drug Amnistration for its manufacturing plant located at Tajola in Raigad Dist., Maharashtra. The plant, which will make Active Pharmaceutical Ingredients is…

Zydus Cadila ties up with Takeda Pharmaceuticals for chikungunya vaccine

Zydus Cadila ties up with Takeda Pharmaceuticals for chikungunya vaccine

2016-09-20T11:43:23+00:00 On

Zydus Cadila, a global healthcare provider, and Takeda Pharmaceutical Company Limited, one of the world´s largest pharmaceutical companies, announced a partnership to develop vaccine for chikungunya, an emerging infectious disease. The broadbased agreement includes early stage development to the final commercialisation of the vaccine…